Cancer Center Amsterdam

Surface downmodulation of TIM3 safeguards healthy cells but not acute myeloid leukemia from CAR T-cell therapy

van der Schans, J. J., Vishwasrao, P., Poels, R., Antti, M., Wang, Z., Quik, M., van Arkel, J., Reuvekamp, T., van de Donk, N. W. C. J., Themeli, M., Ossenkoppele, G. J., van de Loosdrecht, A. A., Richards, R. & Mutis, T., 1 Jul 2025, In: HemaSphere. 9, 7, e70155.

Research output: Contribution to journal › Article* › Academic › peer-review

Bispecific CD33/CD123 targeted chimeric antigen receptor T cells for the treatment of acute myeloid leukemia

Boucher, J. C., Shrestha, B., Vishwasrao, P., Leick, M., Cervantes, E. V., Ghafoor, T., Reid, K., Spitler, K., Yu, B., Betts, B. C., Guevara-Patino, J. A., Maus, M. V. & Davila, M. L., 19 Dec 2023, In: Molecular therapy oncolytics. 31, 100751.

Research output: Contribution to journal › Article* › Academic › peer-review

Emerging CAR T Cell Strategies for the Treatment of AML

Vishwasrao, P., Li, G., Boucher, J. C., Smith, D. L. & Hui, S. K., 1 Mar 2022, In: Cancers. 14, 5, 1241.

Research output: Contribution to journal › Review article* › Academic › peer-review